ArticleCancers2018

Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response.

Jacqueline F Donoghue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.